Market Positioning Daiichi Sankyo España operates within a global top tier pharmaceutical company with a strong focus on cardiovascular and cancer therapeutics, presenting opportunities to cross-sell advanced biologics or specialty medicines to a network of hospitals and clinics in Spain and across Europe.

R&D Emphasis With above-market investment in research and development, there is potential to partner on clinical trials, companion diagnostics, or early access programs for innovative therapies that align with European healthcare priorities.

Expansion Readiness Active presence in Spain since 1964 and multinational footprint suggest readiness for regional partnerships, distribution agreements, and local manufacturing collaborations to scale new products quickly in Iberia and neighboring markets.

Digital & Analytics Adoption of diverse tech tools and digital channels indicates openness to data-driven marketing, payer analytics, and digital engagement solutions to support product launches, market access, and customer education.

Talent & Partnerships A substantial workforce and international career opportunities imply potential for partner-led training programs, medical affairs collaborations, and joint capability-building with healthcare professionals and patient organizations.